Showing posts with label Lung Cancer. Show all posts
Showing posts with label Lung Cancer. Show all posts

Tuesday, February 21, 2023

Understanding Importance of Tech Advancements in Lung Cancer Surgery

How you get affected by Lung Cancer?

 

Lung cancer can cause a wide range of symptoms, depending on the type and stage of the cancer. Symptoms may include coughing, chest pain, shortness of breath, wheezing, and weight loss. Lung cancer can also spread to other parts of the body, causing symptoms such as bone pain, headache, and neurological changes. Treatment may include surgery, radiation, chemotherapy, targeted therapy, or immunotherapy.

 

Why do We Need Advanced Lung Cancer Surgery Techniques?

 

  • Advanced lung cancer surgery techniques can:
  • Provide more accurate diagnosis and treatment of lung cancer, as well as less invasive procedures.
  • Enable surgeons to achieve better outcomes with less discomfort and shorter recovery times for patients.
  • Allow for the removal of small tumors and other lesions that may be difficult to detect with traditional methods.
  • Help to reduce the risk of recurrence and spread of cancer cells to other parts of the body.
  • Also reduce the need for chemotherapy and radiation, as well as improve the quality of life for patients.

 

Major Growth Driving Factors:

 

Market growth is largely driven by factors such as the technological advancements in lung cancer treatment, the increasing incidence and prevalence of lung cancer, the growing trend of smoking tobacco, the rising geriatric population, the increasing emphasis on early diagnosis and treatment of cancers, and the availability of reimbursement. However, the high cost of lung cancer diagnosis and surgery is expected to restrain the growth of this market during the forecast period.

 

Download the PDF Brochure for More Details

 

Emerging Innovations:

 

  • Robot-Assisted Thoracic Surgery: This type of surgery utilizes a robotic system to allow surgeons to perform minimally invasive thoracic procedures with greater precision and accuracy. The robotic system is designed to enable surgeons to make precise, small incisions and access areas of the chest that would otherwise be difficult to reach using traditional open surgery techniques.
  • Video-Assisted Thoracic Surgery (VATS): This type of surgery utilizes a small video camera and other instruments that are inserted through small incisions in the chest wall. This minimally invasive technique allows surgeons to perform operations within the chest cavity with enhanced accuracy and precision. It is often used to perform lobectomies, mediastinal tumor resections, and other surgical procedures.
  • CyberKnife Radiosurgery: CyberKnife radiosurgery is a non-invasive procedure that uses precise doses of radiation to target and destroy cancerous tumors. This technology can be used to treat small, early-stage lung tumors that may not be suitable for traditional open or minimally invasive surgery.
  • Image-Guided Surgery: Image-guided surgery is a technique that uses imaging technology to help guide surgeons during a procedure. This technology can be used to identify the exact location of tumors and other abnormalities in the chest, allowing surgeons to perform accurate, less invasive procedures.


Geographical Growth Dynamics:

 

The global lung cancer surgery industry is experiencing significant geographic growth dynamics. The market for lung cancer surgery has grown significantly in the past few years due to increasing rates of lung cancer diagnosis and the introduction of new technologies. The growth of the market is driven by increased awareness of the need for treatment and preventive measures, improved access to diagnostic and therapeutic services, and the development of new treatments.

 

North America dominates the market, followed by Europe and Asia Pacific. In North America, the US is the largest market, followed by Canada and Mexico. Europe is second in terms of market share, followed by Asia Pacific. The growth of the market in Europe is mainly attributed to the increasing incidence of lung cancer and the growing awareness of the need for treatment.

 

In Asia Pacific, the growth of the market is mainly driven by the increasing prevalence of lung cancer and the availability of advanced technologies and treatments. Furthermore, the rising awareness of preventive measures and improved access to diagnosis and treatments are also driving the growth of the market in Asia Pacific.

 

The Middle East and Africa are still in the early stages of market growth. In the Middle East, the growing awareness of the need for treatment and the availability of advanced technologies and treatments are expected to drive the growth of the market. In Africa, the rising prevalence of lung cancer and the increasing access to diagnostic and therapeutic services are expected to drive market growth.

 

You Can Also Get All Your Queries Answered by Our Experts, Here..!

 

Recent Developments, Globally:

 

  • Robotic Surgery: Robotic surgery is becoming increasingly popular in the treatment of lung cancer, as it offers more precise control of surgical instruments and less invasive procedures. Robotic surgery allows for a more precise removal of tumors and other structures, with less risk of complications and shorter recovery times.
  • Minimally Invasive Surgery: Minimally invasive surgery has become increasingly popular for lung cancer surgery as it requires smaller incisions and fewer complications. This type of surgery also allows for faster recovery times, reduced pain, and less scarring.
  • 3D Imaging: 3D imaging technology has improved the accuracy of lung cancer surgery, making it easier to identify and target tumors and other areas of concern. This can help reduce the risk of complications and improve overall outcomes.
  • Nanotechnology: Nanotechnology is being used in lung cancer research to improve the accuracy of diagnosis and treatment. This technology can be used to detect cancer cells at an early stage, monitor and track tumor growth, and deliver targeted treatments.
  • Immunotherapy: Immunotherapy is being used in combination with other treatments to better target cancer cells and reduce the risk of recurrence. This type of therapy uses the body’s own immune system to fight the cancer.

Thursday, September 29, 2022

Emerging Technological Advancements in Lung Cancer Surgical Procedures

 Global Industry Growth Boosting Factors:


# Increasing incidence of lung cancer
# Increasing emphasis on early diagnosis & treatment of cancers
# Rising technological advancements in lung cancer treatment
# Availability of reimbursements

Overview of This Study:

This study involved four major activities in estimating the current size of the lung cancer surgery market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

COVID-19 Impact on Global Lung cancer treatment market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 moved from a regional crisis to a global pandemic in just a few weeks. The number of cancer screening and diagnostic procedures declined precipitously, with countries worldwide affected by the pandemic. An initial analysis of the US market shows that newly diagnosed metastatic non-small-cell lung cancer patient volumes have declined just over 30% from February 2020 to March 2020—this represents a major decline in just one month. This also impacted rate of surgeries that benefit certain patients.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222

Expected Growth Rate:

The global lung cancer surgery market is projected to be growing at a healthy rate of 3.8% during the forecast period.

Major Objectives of This Study:

# To define, describe, and forecast the lung cancer surgery market, by surgical devices, surgical procedures, and region.

# To provide detailed information regarding the major factors influencing the growth of the lung cancer surgery market (drivers, restraints, opportunities, and challenges).

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.

# To forecast the revenue of lung cancer treatment market segments with respect to four main regional segments, namely, North America, Europe, Asia, and Rest of the World.

# To profile key players in the market and comprehensively analyze their product portfolios, market positions, and core competencies.

# To track and analyze competitive developments such as collaborations, partnerships, acquisitions, expansions, and product launches in the lung cancer surgery market.

# To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

Challenges: The dearth of skilled oncologists

To achieve better outcomes, lung cancer surgeries are performed by skilled professionals. These surgeries are considered to involve more risks when compared to other surgeries due to challenges such as air leaks, movement of tumors due to breathing, and accumulation of fluids in the chest during the procedure. Over the years, the incidence and prevalence of lung cancer have increased and are expected to increase further in the coming years. However, there has not been a subsequent growth in the number of oncologists; this situation is more pronounced in developing countries. The rise in demand is driven by factors like the aging and growth of the population and improvements in cancer survival rates; however, the slow/ lagged growth in the skilled labor is attributed to factors like the oncology workforce is aging and retiring in increasing numbers.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=222

Geographical Growth Dynamics:

North America is the largest regional market for lung cancer surgery market

In 2020, North America accounted for the largest market share. The large share of North America can be attributed to rising technological advancements in lung cancer treatment, increasing incidence and prevalence of lung cancer, rising trend of smoking tobacco, increasing emphasis on early diagnosis & treatment of cancers, and the availability of reimbursement.

Key Developments, Globally:

# In May 2021, Olympus Corporation (Japan) launched BF-UC190F endobronchial ultrasound (EBUS) bronchoscope.

# In February 2020, Intuitive Surgical Inc. (US) acquired Orpheus Medical (US).

# In October 2019, KLS Martin Group (Germany) opened a new training center at its site in Jacksonville, Florida, US.

Read the Detailed Report@ https://www.prnewswire.com/news-releases/lung-cancer-surgery-market-worth-6-7-billion-by-2026--exclusive-report-by-marketsandmarkets-301306639.html

Friday, March 25, 2022

Lung Cancer Surgery Market - Emerging Trends & Global Future Forecasts

 Overview:


This study involved four major activities in estimating the current size of the lung cancer surgery market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Expected Revenue Growth:

The global lung cancer surgery market is projected to reach USD 6.7 billion by 2026 from USD 5.4 billion in 2020, at a CAGR of 3.8% during the forecast period.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222

Major Growth Boosting Factors:

Market growth is largely driven by factors such as the technological advancements in lung cancer treatment, increasing incidence and prevalence of lung cancer, growing trend of smoking tobacco, rising geriatric population, increasing emphasis on early diagnosis & treatment of cancers, and availability of reimbursement. However, the high cost of lung cancer diagnosis & surgery is expected to restrain the growth of this market during the forecast period.

Driver: Increasing incidence of lung cancer

Cancer is the second-leading cause of death worldwide, accounting for 10 million deaths in 2020. Globally, about 1 in 6 deaths occur due to cancer (Source: World Health Organization). 19.3 million new cases were reported in 2020. The increase in cancer incidence at a global scale also indicates an increasing trend for the prevalence of lung cancers worldwide. In this scenario characterized by a favorable funding environment and effective treatment options, the growing incidence and prevalence of cancer are expected to increase the number of patients opting for lung cancer surgery in the coming years. This, in turn, is expected to drive the growth of the market in the coming years.

Restraint: The high cost of lung cancer diagnosis & treatments

Lung cancer treatments are primarily divided into four broader categories; diagnosis/imaging, surgeries, pharmacological assistance, and indirect costs (like transportation, caregiver wages, lodging, secondary effects treatments, and lost wages/ incomes). These categories incur substantial spending from government/insurance providers and additional costs paid by the patient itself. The hefty costs for treating lung cancers have created a substantial burden on the governments globally and cancer patients. Considering these high costs, despite the presence of a large patient pool, a limited number of patients opt for surgical interventions to treat their condition. This is a major factor restraining market growth.

Challenges: The dearth of skilled oncologists
To achieve better outcomes, lung cancer surgeries are performed by skilled professionals. These surgeries are considered to involve more risks when compared to other surgeries due to challenges such as air leaks, movement of tumors due to breathing, and accumulation of fluids in the chest during the procedure. Over the years, the incidence and prevalence of lung cancer have increased and are expected to increase further in the coming years. However, there has not been a subsequent growth in the number of oncologists; this situation is more pronounced in developing countries. The rise in demand is driven by factors like the aging and growth of the population and improvements in cancer survival rates; however, the slow/ lagged growth in the skilled labor is attributed to factors like the oncology workforce is aging and retiring in increasing numbers.

North America is the largest regional market for lung cancer surgery market

In 2020, North America accounted for the largest market share. The large share of North America can be attributed to rising technological advancements in lung cancer treatment, increasing incidence and prevalence of lung cancer, rising trend of smoking tobacco, increasing emphasis on early diagnosis & treatment of cancers, and the availability of reimbursement.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=222

Recent Developments:

In May 2021, Olympus Corporation (Japan) launched BF-UC190F endobronchial ultrasound (EBUS) bronchoscope.

In February 2020, Intuitive Surgical Inc. (US) acquired Orpheus Medical (US).

In October 2019, KLS Martin Group (Germany) opened a new training center at its site in Jacksonville, Florida, US.

Thursday, February 17, 2022

Lung Cancer Surgery Market worth $6.7 billion by 2026

 According to the new market research report, "Lung Cancer Surgery Market by Instrument ((Clamps, Foreceps, Trocars, Retractors, Scissors), Monitoring & Endoscopic Devices), Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), MIS), Volume Data - Global Forecast to 2026", The global lung cancer surgery market is projected to reach USD 6.7 billion by 2026 from USD 5.4 billion in 2020, at a CAGR of 3.8% during the forecast period.


Browse and in-depth TOC on "Lung Cancer Surgery Market"
182 - Tables
27 - Figures
163 - Pages

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222

Global Industry Growth Boosting Factors:

Market growth is largely driven by factors such as the technological advancements in lung cancer treatment, increasing incidence of lung cancer, rising trend of smoking tobacco, rising geriatric population, the increasing emphasis on early diagnosis & treatment of cancers, and availability of reimbursement. However, the high cost of lung cancer diagnosis & surgical treatments is expected to restrain this markets growth during the forecast period. The increasing adoption of refurbished imaging systems.

The powered surgical equipment segment accounted for the largest share of the lung cancer surgery market, by surgical instruments segment, in 2020

Based on surgical instruments, the lung cancer surgery market is segmented into powered surgical equipment and hand Instruments. In 2020, the powered surgical equipment segment accounted for the larger share of the global lung cancer surgery market. Power surgical equipment saves the time required for surgical procedures by showcasing consistent performance and optimum functionality. These are the main factors driving the adoption of powered surgical equipment over hand instruments.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=222

Thoracotomy segment to register the largest share during the forecast period

Based on procedures, the lung cancer surgery market is segmented into thoracotomy and minimally invasive surgeries. In 2020, the thoracotomy segment accounted for the larger share of the lung cancer surgery market. However, the minimally invasive surgeries segment is expected to grow at the highest CAGR during the forecast period. The growing adoption of minimally invasive techniques, increasing technological advancements, availability of reimbursement policies, and the increasing trend of robotic surgeries are the factors driving the growth of this market segment.

Geographical Growth Scenario: 

North America is the largest regional market for lung cancer surgery market

In 2020, North America accounted for the largest market share. The large share of North America can be attributed to rising technological advancements in lung cancer treatment, increasing incidence and prevalence of lung cancer, rising trend of smoking tobacco, increasing emphasis on early diagnosis & treatment of cancers, and the availability of reimbursement.

Key Players:

The prominent players in the global lung cancer surgery market are Accuray Inc. (US), AngioDynamics Inc. (US), Ethicon Inc. (US), Intuitive Surgical Inc. (US), Olympus Corporation (Japan), Teleflex Incorporated (US), Ackermann Instrumente GmbH (Germany), KARL STORZ GmbH (Germany), Scanlan International Inc. (US), TROKAMED GmbH (Germany), Medtronic Plc. (Ireland), Siemens Healthcare (Germany), Richard Wolf GmbH (Germany), Phoenix Surgical Holdings Limited (England), Key Surgical LLC (US), Surgical Holdings (England), FusionKraft (India), KLS Martin Group (Germany), Sontec Instruments Inc. (US), and Wexler Surgical Inc. (US).

Speak to Analyst@
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=222